Skip to main content
OPKO Health Inc. logo

OPKO Health Inc. — Investor Relations & Filings

Ticker · OPK ISIN · US68375N1037 LEI · 529900A4S2D4OGOJLL02 TA Human health and social work activities
Open in API
Filings indexed 3,780 across all filing types
Latest filing 2025-05-02 Earnings Release
Country US United States of America
Listing TA OPK

About OPKO Health Inc.

https://www.opko.com

OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.

Recent filings

Filing Released Lang Actions
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
Earnings Release Classification · 98% confidence The document is explicitly titled 'FORM 8-K' and 'CURRENT REPORT' filed with the 'UNITED STATES SECURITIES AND EXCHANGE COMMISSION'. Item 2.02 specifically discusses 'Results of Operations and Financial Condition' for the quarter ended March 31, 2025, referencing an attached press release (Exhibit 99.1) that contains the detailed financial highlights. A Form 8-K is used to announce major events that shareholders should know about promptly. While it contains financial results, the primary filing mechanism here is the 8-K, which is a general current report. Since '10-K' is for the *Annual* Report and 'IR' is for the *Interim/Quarterly* Report, and this is a specific SEC current report form (8-K) announcing quarterly results and other material events (like the Labcorp sale and stock repurchase authorization), the most appropriate classification among the provided options that captures a comprehensive, non-scheduled regulatory filing announcing material events is often the general 'Regulatory Filings' (RNS) or, if the focus is heavily on the quarterly results announcement, 'ER' (Earnings Release) or 'IR' (Interim Report). However, Form 8-K is a distinct regulatory filing type. Given the options, and recognizing that the 8-K is the official vehicle used to disseminate this information (which includes earnings highlights, M&A updates, and capital changes), 'RNS' (Regulatory Filings - general fallback) is the safest classification for a Form 8-K that doesn't perfectly align with the specific definitions of 10-K, IR, or ER (which are usually press releases). Since the document is a full SEC filing (Form 8-K) and not just a press release, and it covers multiple material items beyond just earnings, RNS is the best fit as a catch-all for specific SEC forms not listed, or we must evaluate if it fits ER or IR better. It reports on the first quarter (IR period), but the document *is* the 8-K filing itself. Because the document is a comprehensive SEC filing (Form 8-K) reporting on multiple material events (Item 2.02 Results, Item 1.01 Material Definitive Agreement), it falls best under the general regulatory filing category. Q1 2025
2025-05-02 English
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
Earnings Release Classification · 95% confidence The document is very short (1890 characters) and explicitly states: "Attached hereto is a report on *Form 8-K OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results* ". This structure indicates that the document itself is an announcement about the release of another report (the Form 8-K), rather than the full financial report (which would typically be an IR or ER if it contained the full results). Since it is an announcement regarding the publication of a filing, and it is not a standard quarterly/annual report, it fits best under the Report Publication Announcement (RPA) category, as per the 'MENU VS MEAL' rule, or potentially RNS as a general regulatory filing announcement. Given the context of announcing a specific filing (Form 8-K), RPA is the most precise fit. Q1 2025
2025-05-02 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Alice Lin-Tsing Yu, M.D., Ph.D
Director's Dealing Classification · 100% confidence The document explicitly contains the header "FORM 4" and "STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934". Form 4 filings are used by insiders (directors, officers, or 10% owners) to report changes in their beneficial ownership of the company's securities. This specific filing relates to transactions by a director (Alice Lin-Tsing Yu, M.D., Ph.D.) and details the acquisition of stock options. This directly corresponds to the definition of Director's Dealing (insider trades). Therefore, the classification is DIRS.
2025-04-23 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Alice Lin-Tsing Yu, M.D., Ph.D
Report Publication Announcement Classification · 98% confidence The document is a short regulatory filing (1780 chars) issued by OPKO HEALTH, INC. It is titled 'Interested party transaction - Yu' and explicitly states, 'Attached hereto is a report on *Interested party transaction - Yu 20250423Form4Yu_isa.pdf*'. This structure—a brief announcement referencing an attached or linked document—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. While it relates to a transaction, the document itself is the announcement of the filing, not the detailed transaction report (which would likely be classified under LTR or potentially RNS if no other category fits, but RPA is more specific for publication notices). The reference to 'Form 4' in the attached file name suggests an insider transaction, but the primary function of this specific text is announcing the publication of that report.
2025-04-23 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Richard C. Pfenniger, Jr
Director's Dealing Classification · 99% confidence The document text explicitly contains the header "FORM 4" and "STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES". Form 4 is the standard SEC filing used to report changes in beneficial ownership of securities by insiders (directors, officers, or 10% owners). This type of filing specifically relates to insider transactions, which aligns directly with the definition for Director's Dealing (DIRS) in the provided schema, although the schema does not have a specific 'Form 4' code. However, looking at the provided definitions, 'Director's Dealing (Code: DIRS)' is defined as 'Report of personal share transactions by company directors and executives (insider trades)'. Form 4 is the primary document for reporting insider trades. Therefore, DIRS is the most appropriate classification.
2025-04-23 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Richard C. Pfenniger, Jr
Report Publication Announcement Classification · 98% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). The content explicitly states: 'Attached hereto is a report on *Interested party transaction - Pfenniger* *20250423Form4Pfenniger_isa.pdf*'. This structure—a brief announcement stating that a specific report (in this case, related to an interested party transaction, which often involves insider dealings or related-party disclosures) is attached or published—fits the definition of a Report Publication Announcement (RPA). While the subject matter (interested party transaction) might suggest DIRS or LTR, the document itself is merely the notification of the attached report, making RPA the most accurate classification based on the 'MENU VS MEAL' rule.
2025-04-23 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.